On February 3, 2020, Cerecor Inc. consummated its two-step merger with Aevi Genomic Medicine Inc., in accordance with the terms of a previously disclosed Agreement and Plan of Merger and Reorganization, dated as of December 5, 2019, by and between Cerecor, Genie Merger Sub Inc., Second Genie Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Cerecor, and Aevi . Effective upon the consummation of the Merger, Cerecor's board of directors was increased from seven to nine board seats and Sol J. Barer, Ph.D and Michael F. Cola were appointed to the board. Accordingly, immediately following the effective time of the Merger, the directors serving on the board of directors of Cerecor are: Dr. Barer, Steven J. Boyd, Mr. Cola, Peter Greenleaf, Phil Gutry, Uli Hacksell, Ph.D., Keith Schmidt, Magnus Persson, M.D., Ph.D., and Simon Pedder, Ph.D., who serves as Executive Chairman of the board of directors.

Dr. Barer and Mr. Cola served as directors of Aevi prior to the closing of the Merger. The Cerecor board of directors has affirmatively determined that all Cerecor directors, except for Mr. Cola, Dr. Pedder, and Mr. Greenleaf, are independent directors within the meaning of the applicable Nasdaq listing standards. The members of Cerecor's audit committee, compensation committee and nominating and corporate governance committee did not change following the consummation of the Merger and all members of such committees are independent directors under the applicable Nasdaq listing standards.

Effective upon the consummation of the Merger, Cerecor entered into an employment agreement with Mr. Cola for him to serve as Cerecor's Chief Executive Officer and an employment agreement with Dr. Garry A. Neil for him to serve as Cerecor's Chief Medical Officer. Mr. Cola, 60, served as Aevi's President and Chief Executive Officer from September 2013 until February 2020. Mr. Cola, 60, served as Aevi's President and Chief Executive Officer from September 2013 until February 2020.

Dr. Neil, 66, joined Aevi in September 2013. Prior to that, Dr. Neil was a Partner at Apple Tree Partners.